Kate Brinkley-Talley represents and counsels a broad range of healthcare and pharmaceutical clients on healthcare regulatory, litigation, and public policy issues.

Ms. Brinkley-Talley's practice includes representing healthcare providers, suppliers, and pharmaceutical manufacturers on matters related to federal and state healthcare fraud and abuse issues (including the federal False Claims Act, Stark Law, and Anti-Kickback Statute). As part of her practice, Ms. Brinkley-Talley represents clients in criminal and civil investigations brought by the government, and also conducts internal compliance investigations.

The regulatory component of her practice includes counseling clients on Medicare and Medicaid coverage and reimbursement considerations, on healthcare licensing and credentialing, on health information privacy and security compliance (HIPAA and state privacy laws), on drug pricing matters (including the 340B program, the Medicaid Drug Rebate Program, and the Medicare Part B drug price reporting requirements), on compliance issues concerning participation in the Medicare and Medicaid programs, and on other regulatory and legislative developments affecting the healthcare industry. Additionally, Ms. Brinkley-Talley has experience representing clients in connection with administrative and Congressional advocacy.

Her transactional practice focuses on advising clients on the regulatory, structuring, and business considerations in healthcare business transactions and contractual arrangements.


  • JD, The George Washington University Law School, 2013, with Honors
  • Graduate Certificate in Health Policy, The George Washington University School of Public Health & Health Services, 2013
  • BS, Public Health, The George Washington University, 2007, magna cum laude
  • District of Columbia

Email Disclaimer